Immunotherapy & Vaccines
This session explores
immunotherapy
innovations and therapeutic cancer
vaccines as transformative strategies in oncology.
Topics will include checkpoint inhibitors, adoptive T-cell therapies,
tumour-specific vaccines, and immune modulators.
Experts will examine
mechanisms of immune resistance and biomarker-driven personalisation of immunotherapies. Combination
strategies to enhance efficacy and overcome limitations of monotherapies will
be highlighted.
Subtracks:
- Checkpoint Inhibitor Therapy Developments
- Therapeutic Cancer Vaccines
- Biomarkers for Immunotherapy Response
- Combination Immunotherapy Strategies
- Immune Escape and Resistance Mechanisms
- T-cell Based Adoptive Immunotherapies